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Thousands of protein acyl modification sites have now been identified in vivo. However, 
at most sites the acylation stoichiometry is low, making functional enzyme-driven 
regulation in the majority of cases unlikely. As unmediated acylation can occur on the 
surface of proteins when acyl-CoA thioesters react with nucleophilic cysteine and lysine 
residues, slower non-enzymatic processes likely underlie most protein acylation. Here 
we review how non-enzymatic acylation of nucleophilic lysine and cysteine residues 
occurs, the factors that enhance acylation at particular sites, and the strategies that 
have evolved to limit protein acylation. We conclude that protein acylation is an 
unavoidable consequence of the central role of reactive thioesters in metabolism. 
Finally, we propose a hypothesis for why low-stoichiometry protein acylation is selected 
against by evolution and how it might contribute to degenerative processes such as 
aging. 
Introduction 
Numerous different acyl-CoA species arise in metabolism (Supplementary Table 1), and 
many have been shown by mass spectrometry (MS) to generate corresponding acyl-lysine 
modifications on proteins in vivo [1-7]. However, with the exception of those catalyzing 
histone acetylation, few enzymes that transfer acyl groups to protein have been identified [8]. 
Recent work has challenged the importance of enzymatic protein acylation at most sites, as 
the observed median stoichiometry of N-acetylation is ~0.1% [9, 10]. The lack of enzymes 
that transfer acyl groups to protein, the broad range of acyl-lysine modifications, the low 
stoichiometry of acylation, and the vast number of acylation sites suggest that most lysine N-
acylation arises non-enzymatically. The mechanism and stoichiometry of protein acylation 
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 2 
are crucial for understanding links between deacylating sirtuin enzymes and degenerative 
processes such as aging [11-13], as high stoichiometry enzymatic acylation of specific sites 
may be regulatory, while low stoichiometry non-enzymatic acylation of many sites suggests a 
stress [14, 15]. 
 
Kinetics and thermodynamics of non-enzymatic acylation 
To understand the likelihood of non-enzymatic protein acylation, first consider the law of 
mass action which is composed of two key parts: first the reaction rate is proportional to the 
product of the reactant concentrations; and the ratio between the concentration of reactants 
and products is constant at equilibrium. The first part dictates that the rate of non-enzymatic 
protein acylation depends upon the local acyl-CoA and nucleophile concentrations. The 
second part is relevant as energy from the continual oxidation of carbohydrates, fats and 
amino acids causes a displacement from equilibrium of couples such as the acyl-CoA/CoA 
ratio. The chemical potential energy in these couples creates a directional flux as acyl-CoAs 
are synthesized by certain reactions and consumed by others. Although metabolic flux largely 
flows through enzymatically catalyzed pathways, the chemical potential energy of acyl-
CoA/CoA couples can also drive slower non-enzymatic side reactions. Thus, the key question 
is not whether slower non-enzymatic acyl-transfer reactions to protein residues can occur [16, 
17], but whether they are fast enough to occur within biological timeframes [18]. For 
example, carbonic anhydrase enhances the rate of CO2 hydration a billion-fold, but the half-
life of the non-enzymatic process is still only 5 s. In contrast, the non-enzymatic half-life of 
some biologically important reactions is millions of years making enzymatic catalysis 
essential [18]. Non-enzymatic acyl-transfer from acyl-CoAs to protein residues falls between 
these extremes with the in vivo half-life of reversible SS-transfer of an acyl moiety to 
another thiol ~10 M-1s-1 [16]. This suggests meaningful reversible SS-transfer occurs 
within minutes to hours while irreversible SN-transfer of an acyl moiety to an amine takes 
hours to days [16, 18-20]. 
 
CoA and acyl-CoAs 
Non-enzymatic protein acylation by acyl-CoAs depends on their cellular concentrations, and 
these are intimately linked to that of CoA itself, which is synthesized from ATP, cysteine and 
pantothenate (vitamin B5) by five essential enzymes [21, 22]. Pantothenate biosynthesis is 
dispensable in animals, which have a pantothenate transporter for uptake from the gut [21, 
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22]. The first committed step in CoA biosynthesis is the ATP-dependent conversion of 
pantothenate to cell-impermeant 4-phosphopantothenate, which is catalyzed by four isoforms 
of pantothenate kinase (PanK) [23]. The external supply of pantothenate, the level of 
expression of each PanK isoform and feedback inhibition of PanK by CoA and its thioesters 
collectively control CoA biosynthesis [24]. The size of the combined pool of CoA and its 
acylated forms varies widely among mammalian tissues, being largest in the liver at ~150 µM 
[25, 26]. Its subcellular distribution reflects its diverse roles, and ranges from 20-140 µM in 
the cytosol, 700 µM in peroxisomes and 2.2-5 mM in the mitochondria [27-30]. Non-
enzymatic protein acylation is also influenced by how much the acyl-CoA/CoA ratio is 
displaced from equilibrium. Usually ~10-50% of CoA is S-acylated in vivo [29, 31], but this 
will vary depending on cell compartment, tissue and substrate availability.  
Acetyl-CoA is the product of several major metabolic pathways including pyruvate, 
fatty acid and branched-chain amino acid oxidation [32] and these reactions predominantly 
take place in the mitochondrial matrix. Acetyl-CoA is also generated in the cytosol where 
ATP is used to make acetyl-CoA from acetate and cleave citrate into oxaloacetate and acetyl-
CoA [32]. Many other acyl-CoAs exist in metabolism, but most participate in fewer reactions 
and thus tend to be compartmentalized within the cell (Supplementary Table 1). This includes 
succinyl-CoA, an intermediate in the tricarboxylic acid cycle within the mitochondrial 
matrix; malonyl-CoA, a precursor for fatty acid synthesis in the cytosol; and very-long chain 
fatty acyl-CoAs, which are shortened in the peroxisome before transfer to mitochondria to be 
broken down to acetyl-CoA. There are also many minor acyl-CoAs that are intermediates in 
other metabolic pathways, such as amino acid catabolism (Supplementary Table 1). MS has 
identified corresponding acyl-lysine modifications for many acyl-CoAs [1-7, 33], but 
dedicated transferases have remained elusive raising the possibility such enzymes do not 
exist. 
 
The chemistry of non-enzymatic lysine N-acylation 
Protein acylation, whether it is enzymatic or non-enzymatic, is a nucleophilic acyl 
substitution reaction where a nucleophile attacks the carbonyl of a thioester such as an acyl-
CoA. This implies non-enzymatic protein acylation is inevitable in vivo, because of the 
ubiquity of nucleophiles on protein surfaces. However, the rate of non-enzymatic protein 
lysine N-acylation at individual sites will be relatively slow as only ~0.1% of solvent-
exposed lysine residues are in the nucleophilic, deprotonated form (pKa ~10.5) in the cytosol. 
Acyltransferases can circumvent this constraint using active site ionizable residues to keep 
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 4 
lysines deprotonated (Figure 1A). While individual surface lysine residues are less reactive 
than corresponding active site nucleophiles, as a group they are more abundant. The total 
concentration of surface-exposed protein lysine residues in a tissue is ~100 mM giving a 
nucleophilic amine concentration of ~100 µM (see Supplemental Calculations). As the 
concentration of metabolic enzymes, and thereby their stabilized active site nucleophiles, is 
generally below 100 µM [34], it is realistic that surface lysine residues as a group can 
compete with metabolic pathways for acyl-CoAs. This is especially true in the mitochondrial 
matrix where the higher pH and elevated  acyl-CoA and protein concentrations will combine 
to further favor non-enzymatic acylation [9, 17, 27-29, 33-35].  
 
Abundance and stoichiometry of lysine N-acylation 
Sites of protein lysine N-acylation are identified through trypsinization, followed by 
enrichment of N-acylated peptides with an antibody against the acyl-lysine residue and MS 
analysis (Box 1) [1-7]. These studies typically generate long lists of lysine residues that are 
modified in vivo and with recent improvements in MS sensitivity several thousand sites can 
be identified [36]. However, MS still preferentially observes easily detectable peptides on 
abundant proteins, suggesting current observations underestimate protein N-acetylation sites 
(there are ~700,000 unique lysine residues encoded by the mouse transcriptome and typically 
~95% of lysines are solvent exposed) [5, 37, 38]. While there are many such lists of protein 
acylation sites, identifying those sites used for metabolic regulation is difficult because 
stoichiometric analysis of the extent of acylation of each site remains rare [36]. Recent 
analysis of ~4000 lysine N-acetylation sites in mouse liver observed only one site N-
acetylated by >10%, with median N-acetylation at each site of just ~0.1% [9]. This low 
stoichiometry is also observed in Escherichia coli and is consistent with calculated values 
obtained by calibrating in vivo acetylation against proteins labelled in vitro with 14C acetyl-
CoA [10, 20]. The low stoichiometry of lysine N-acetylation suggests that at most sites N-
acylation is stochastic and that regulatory acetylation is the exception rather than the rule.  
 
Cysteine and other nucleophilic protein residues can also be acylated 
Protein acylation could occur on other nucleophilic residues, such as serine, threonine, 
histidine and cysteine. Serine and threonine residues often act as the nucleophiles within 
enzyme active sites, but are weak nucleophiles in the absence of ionizable groups to aid 
deprotonation. Even so, the SO-transfer of acetyl groups from a thioester to a serine 
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 5 
residue generating an O-linked acetyl-serine modification was observed on peptides [20], so 
esterified serine and threonine acyl modifications might occur in vivo. While histidine 
residues are predominantly in their reactive, deprotonated form (pKa ~6) within the cell and 
can in principle be N-acylated, their importance in vivo may be limited as N-acyl-histidine 
residues are unstable [39]. 
In contrast, cysteine S-acylation may be important as the pKa (~8.5) of the cysteine 
thiol means ~10% is in the reactive thiolate form in the cytosol, and the thioester bond of S-
acylcysteine is moderately stable. Consistent with their relative pKa values, acetyl-CoA 
acetylated cysteine residues ~100-fold more rapidly than lysine residues at pH 7.8 in vitro 
[20]. This reactivity may help explain why cysteines residues are sparse on protein surfaces 
[35, 38, 40] with a tissue concentration of exposed protein cysteine residues of ~20 mM. 
However, despite the low frequency of cysteine residues the nucleophilic thiolate 
concentration (~2 mM) is actually greater than for lysine (see Supplemental Calculations). 
Thus, in the absence of mitigation, non-enzymatic S-acylation of cysteine residues will be a 
significant modification in vivo, particularly within mitochondria. 
Why then is the literature on cysteine S-acylation so limited compared to lysine N-
acylation? The reason is that non-enzymatic protein S-acylation is difficult to explore by MS 
in vivo because the thioester bond can hydrolyze or further react with nucleophiles during 
overnight trypsinization prior to MS analysis (Box 1). Thus, protein S-acylation is observed 
indirectly through blocking of free thiols, selective removal of the acyl group with 
hydroxylamine, followed by derivatization of the previously S-acylated free thiol [41]. While 
such chemical deacylation followed by derivatization is suitable for high stoichiometry 
enzyme-catalyzed sites, low stoichiometry protein S-acylation may be difficult to 
differentiate from chemical artifacts [20, 35]. Consequently, non-enzymatic protein S-
acylation has largely been explored in vitro on peptides where proteolytic cleavage is not 
required and S-acylation can be viewed directly [16, 20, 42]. This suggests significant SS-
transfer of acyl groups between acyl-CoA and protein thiols could be expected in vivo over 
minutes to hours. 
Another key difference between non-enzymatic protein S-acylation and N-acylation is 
reversibility: protein lysine N-acylation forms an amide bond resistant to further nucleophilic 
attack, while protein S-acylation generates another thioester on a surface cysteine residue that 
another nucleophile can remove. The reaction is reversed if the nucleophile is CoA, but this is 
unlikely as >90% of cellular thiols are on glutathione or protein cysteine residues [43]. 
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Furthermore, enzymatic processes will rapidly remake acyl-CoA from CoA generated by off-
target acyl-transfer reactions to protein. This constant flux of acyl-CoA generated by 
metabolism would be expected to cause other thiols to become as S-acylated as the CoA pool. 
However, this is not observed suggesting that S-acyl groups are removed from non-CoA 
thiols, probably via enzyme-mediated hydrolysis [20]. Acyl-CoAs are then resynthesized 
using ATP, suggesting that some metabolic inefficiency is tolerated to minimize off-target 
protein S-acylation, presumably because this is more efficient than using thousands of ATP 
molecules to degrade and remake the damaged protein.  
 
Factors that enhance protein N-acylation at some sites 
One mechanism by which enzymes achieve rate enhancement is through binding,  thereby 
raising the local concentrations of their substrates (Figures 1A and 1C). As thioesters form on 
protein surfaces via SS-transfer of an acyl moiety to a cysteine residue it is likely S-acyl 
modifications cause widespread enhanced N-acetylation of nearby lysine residues. Several 
enzymatic and non-enzymatic examples of an initial SS-acyl-transfer reaction being used to 
enhance a slower localized SN-acyl-transfer to a nearby lysine residue illustrate the 
feasibility of this proximity-enhanced reaction (Figure 1). This two-step process was also 
shown using the peptide RYAKGCASR, which was readily S-acetylated by acetyl-CoA on 
its cysteine residue. This S-acetylation caused nearby lysine and serine residues to be 
acetylated 23-fold faster than on the peptide RYAKGSASR that lacks a thiol [20]. The same 
proximity effect enhances lysine N-acetylation in vivo if cysteine and lysine residues are 
closer than ~10 Å on the protein surface [35]. This reaction distance of ~10 Å is consistent 
with the combined distance of eight bond lengths from the -carbon to the respective amine 
and carbonyls atoms of lysine and S-acyl-cysteine. This distance and their flexible side-
chains imply they interact within a volume of ~103 Å3, thus an amine within range of an S-
acylcysteine is effectively exposed to a local thioester concentration of ~1 M (see 
Supplemental Calculations). For comparison, a physiological acetyl-CoA concentration of 
0.01-1 mM equates to one thioester per ~106-108 Å3. A similar proximity effect is predicted 
to occur if acyl-CoAs associate with nucleotide binding sites on proteins, because CoA, like 
NADH, NADPH, FADH and ATP, contains an ADP backbone that is recognized by proteins 
with a Rossman fold [44].  
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These proximity effects mean the distinction between enzymatic and non-enzymatic 
reactions is somewhat arbitrary and protein acylation will often be auto-catalyzed by nearby 
cysteine residues or nucleotide binding sites (Figure 2, Key Figure).  
 
Low stoichiometry protein acylation is a stress with detrimental consequences 
The above analysis indicates non-enzymatic acylation of exposed protein residues by acyl-
CoAs occurs readily. Consequently, protein acylation in the absence of sufficient deacylation 
may represent a ‘carbon stress’ in much the same way that oxidative stress occurs when 
reactive oxygen species (ROS) generation overwhelms cellular antioxidant systems [14, 15]. 
This hypothesis is attractive as acyl-CoAs, unlike ROS, are central metabolites present at 
relatively high concentrations that cannot be aggressively degraded. It also fits with work 
showing E. coli CobB deacetylase depresses already low stoichiometry lysine N-acetylation 
yet further [10]. However, it remained unclear whether low stoichiometry N-acylation at a 
myriad of sites had detrimental consequences [14]. This was recently addressed by analyzing 
lysine residues with a proximal cysteine residue closer than ~10 Å, as these lysine residues 
exhibit a higher degree of N-acetylation in vivo [35]. If lysine acylation is detrimental such 
sites should experience greater selective pressure and mutation of either the lysine or cysteine 
residue should prevent any deleterious effect [35]. It was shown that mutation of these low 
stoichiometry (<1%) sites of lysine auto-acetylation in mouse liver occurred almost twice as 
frequently in 66 vertebrate genomes than non-acetylated sites from the same proteins [35]. 
Linking low stoichiometry lysine N-acylation with negative selection at hundreds of sites 
strongly supports the carbon stress hypothesis. Intriguingly, the species with the longest 
maximum lifespan exhibited lower conservation of pairs of nearby cysteine and N-acetylated 
lysine residues [35]. This strong correlation with lifespan (p < 0.0001) only held for cytosolic 
proteins despite increased N-acetylation of proteins in the mitochondrial matrix [35]. Thus, 
low stoichiometry lysine N-acylation, not associated with any particular acylation site, may 
be linked to the wide variation in maximum lifespan between species [45, 46].  
 
Evolved strategies to limit or reverse non-specific protein acylation by thioesters 
Given that low stoichiometry lysine N-acylation appears to be a stress [10, 14, 15, 35], it is 
expected that mechanisms have evolved to limit off-target protein acylation (Figure 3). The 
simplest way to do this is to limit the free thioester concentration by binding acyl-CoAs to 
carrier proteins, of which humans have three [47, 48]. Acyl groups can also transit through 
the cytosol to mitochondria as less reactive O-linked acyl-carnitines that do not cause protein 
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lysine N-acetylation [20]. Supporting this protective role, skeletal muscle from mice deficient 
in carnitine acetyltransferase (CrAT) had increased tissue acetyl-CoA levels and 
susceptibility to diet-induced N-acetylation of a range of mitochondrial proteins [49]. 
Another mechanism for limiting acyl-CoA concentration is to hydrolyze it to its cognate 
carboxylic acid and CoA. Despite this process being inefficient, with reconstitution requiring 
ATP, there are 15 acyl-CoA thioesterase (ACoT) genes in mouse and 12 in humans [50]. 
While this suggests the acyl-CoA pool is tightly regulated, the role of ACoTs is still poorly 
understood, and their impact on acylation has yet to be assessed.  
Non-enzymatic SS-transfer of acyl groups from acyl-CoA to protein cysteine thiols 
generates S-acyl cysteine residues on proteins [20]. Glutathione is present at millimolar 
concentrations within tissues and can equilibrate with S-acyl groups on proteins via an SS-
transfer reaction, recovering the protein thiol and forming S-acyl-glutathione [16, 20]. The 
thioesterase, hydroxyacyl glutathione hydrolase (HAGH, also called glyoxalase II), can then 
rapidly hydrolyze S-acyl-glutathione [20]. This is necessary as S-acetyl-glutathione also 
causes unmediated N-acetylation of lysine residues in vitro [20, 51]. By keeping the S-acyl-
glutathione concentration low, S-acyl-groups can be drained from S-acyl-cysteine residues 
and in vitro HAGH limits lysine N-acetylation by acetyl-CoA in the presence of glutathione 
[20]. As the acyl group is bound to glutathione and HAGH recognizes only glutathione, one 
enzyme can indirectly limit a broad range of S- and N-acyl modifications of disparate targets 
[20].  
HAGH is ineffective once an N-acyl lysine modification forms on a protein surface, 
and instead several acyl-specific sirtuin deacetylases (Sirt) remove N-acyl lysine 
modifications from proteins and this has been extensively reviewed [52, 53]. In humans Sirt1, 
Sirt2 and Sirt3 all have efficient deacetylase activity that extends to propionyl-, butyryl- and 
myristoyl-lysine residues. Sirt4 and Sirt5 shows increased specificity towards negatively-
charged succinyl-, malonyl-, glutaryl- and (3-methyl)glutaryl lysine modifications [54, 55]. 
Sirt6 shows selectivity for myristoyl- and palmitoyl-lysine residues [56], while Sirt7 has been 
reported as a desuccinylase [57]. While much work has focussed on the sirtuin family, a 
further 11 Zn-dependent deacetylases can also remove acyl-modifications [58].  
 
Hypothesis: Low stoichiometry acylation prevents effective protein turnover 
While strategies have evolved to limit lysine N-acylation and the majority of it appears 
detrimental [20, 35, 49, 53], it is unclear how low stoichiometry lysine N-acylation of 
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 9 
proteins at a myriad of sites damages the organism. As lysine N-acylation changes a 
positively-charged side-chain into one that is hydrophobic or negatively-charged, high 
stoichiometry enzymatic acylation of a single lysine residue can inactivate enzymes, alter 
interacting partners or change protein localization. Transferase-catalyzed examples of this 
mode of regulation include histone acylation which limits their binding to negatively-charged 
DNA and thereby increases transcription [8], and long-chain acylation of a single cysteine or 
lysine residue to anchor a protein to a membrane [59]. However, these regulatory changes 
can only occur because a high proportion of the protein is modified. Negative selection 
against hundreds of sites of low stoichiometry protein acylation is not consistent with 
regulation and instead implies that there is a common problem introduced by N-acylation of 
proteins [14, 15, 35]. A plausible hypothesis is that lysine acylation increases hydrophobicity 
favoring protein misfolding and aggregation (Figure 4A) and several observations support 
this possibility. Increased protein N-acetylation in E. coli generated larger inclusion bodies 
that were processed more slowly, while decreased N-acetylation led to smaller inclusion 
bodies and their faster processing [60]. N-acetylation of lysine residues triggers aggregation 
of Tau protein leading to neurodegenerative disease [61], and acetylation is decreased by 
mutation of a nearby auto-catalytic cysteine residue [62] (Figure 1D). Tracts of glutamine, a 
similar but less hydrophobic mimetic of N-acetyllysine, lead to insoluble protein aggregates 
in PolyQ disorders such as Huntington’s Disease [63]. Histone deacetylase inhibitors increase 
protein aggregation and bromodomains that bind acetylated protein are enriched in these 
amyloid aggregates [58, 64]. In addition to increased hydrophobicity, N-acylation has another 
effect that might decrease protein turnover and cause aggregation. Degradation of cytosolic 
proteins by the proteasome predominantly occurs by ubiquitination of lysine residues on 
target proteins (Figure 1C). If a lysine is N-acylated it cannot be ubiquitinated, thus lysine N-
acylation could prevent a modified protein from being degraded by the proteasome [65]. That 
mitochondrial matrix proteins are turned over at the level of the organelle rather than 
individually could explain why it is overexpression of the cytosolic/nucleic sirtuins, Sirt1 and 
Sirt 6, that extends lifespan in mice [12, 66]. It is also consistent with knockdown of ATP-
citrate lyase, which generates acetyl-CoA for fatty acid synthesis in the cytosol, extending 
lifespan in flies [67], and the observation maximum lifespan correlates with cytosolic, but not 
mitochondrial matrix N-acylation [35, 52, 68].   
While detrimental pairs of proximal cysteine and lysine residues were identified from 
a protein N-acetylation dataset [9, 35], other non-enzymatic lysine modifications could cause 
negative selection at these sites and thereby underlie the correlation with maximum lifespan 
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[69]. The most problematic could be longer-chain acyl-CoA species as these would generate 
very hydrophobic acyl-lysine modifications at the identified sites through proximity-based 
acyl-transfer reactions (Figure 4A). This is consistent with a similar negative correlation of 
maximum lifespan with plasma long-chain free fatty acid concentrations [70] and lifespan 
extension with overexpression of the long-chain deacylase, Sirt6 [12, 13].  
This hypothesis fits with the long history of dietary restriction extending lifespan [71], 
that this may require autophagy [72], and that autophagy is linked to cytosolic acetyl-CoA 
levels [73, 74]. While limiting non-enzymatic acylation by acyl-CoAs could link dietary 
restriction and lifespan, many questions remain (see Outstanding Questions).  
 
Conclusions 
Given that any thioester can non-enzymatically acylate a primary amine such as the side-
chain of a lysine residue and all living things use thioesters in metabolism, it would appear 
non-enzymatic protein acylation is a very ancient process. This implies the vast majority of 
lysine N-acylation predates regulation and is simply a consequence of cellular protein being 
bathed in reactive thioesters displaced from equilibrium. This non-enzymatic acylation would 
provide a need for general deacylation mechanisms which in turn could facilitate the 
evolution of enzymatic acylation at certain sites as a regulatory modification (Figure 4B). We 
believe that protein acylation should be viewed within this context - many deacetylases will 
be enzymes that keep the surface of other proteins clean and genuine regulatory acetylation 
should be considered the exception rather than the rule.  
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Figure 1. S→S-acyl-transfer followed by a proximity-enhanced S→N-acyl-transfer are 
features of both non-enzymatic and enzymatic reactions. A, enzymatic histone acetylation 
by ESA1 occurs through an active site S-acetyl-cysteine intermediate [75]. B, non-enzymatic 
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native chemical ligation of two peptides [76]. An N-terminal cysteine thiol on peptide 1 
(green) attacks a thioester on the C-terminus of peptide 2 (gray) forming a thioester bond 
between peptides 1 and 2. The proximity of the N-terminal amine favors an S→N-acyl 
transfer and formation of a stable amide bond between peptides 1 and 2. C, enzymatic 
ubiquitination of proteins for degradation [77]. Ubiquitin (Ub) is first conjugated to E1 via a 
thioester before S→S-acyl transfer to E2. E3 generates a proximity effect by localizing S-
ubiquinated-E2 near a target protein. An S→N-acyl transfer forms a stable amide bond 
between ubiquitin and the target protein. D, Tau protein is auto-acetylated. Acetyl-CoA 
acetylates C291 and C322 and these auto-acetylate K280 [62]. Acetylation of K280 leads to 
Tau aggregation [61]. 
 
Key Figure 2. There is no clear distinction between non-enzymatic and enzymatic 
acylation. Acylation at many sites will be enhanced by auto-catalysis and similar reactions 
could be considered enzymatic or non-enzymatic simply because the N-acylated lysine 
residue resides on a different protein. 
 
Figure 3. Non-enzymatic acylation. Reactive S-linked CoA-thioesters (red boxes), such as 
acetyl-CoA, are generated by metabolism. These are transformed into stable O-linked 
carnitines by CrAT or hydrolysed to free acids by ACoTs to prevent them react non-
enzymatically with other nucleophiles. If reactive S-linked thioesters form on protein cysteine 
residues they can exchange with glutathione and be hydrolyzed to the free acid by HAGH. If 
the acetyl group irreversibly transfers to a protein lysine residue then Sirt deacetylases can 
remove it at the expense of NAD. 
 
Figure 4. A, a hypothetical mechanism for low stoichiometry non-enzymatic acylation to 
affect lifespan. B, possible evolutionary sequence of acylation and deacylation. Reactive 
thioesters would have caused slow non-specific non-enzymatic acylation of protein 
nucleophiles. Positive selection generates general deacylation pathways for repair that are 
more efficient that protein degradation and resynthesis. General deacylation pathways in turn 
allow evolution of regulatory enzymatic acylation at certain sites. 
 
Box 1. Measuring acylation 
N-Acylation – Method - Usually overnight trypsinization followed by enrichment of acylated 
peptides with an anti-acyllysine antibody. Advantages – N-acylation is stable so can be 
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observed directly. Limitations – Only detects one modification at a time. No suitable 
antibodies for long-chain acyl groups. Hard to measure all acylation at a site.  
S-Acylation – Method - Usually alkylation of free thiols, followed by deacylation with 
hydroxylamine and alkylation of previously acylated thiols with a tag. This is followed by 
overnight trypsinization and enrichment tagged peptides with an antibody. Advantages -  Can 
measure all acylation at a site. Limitations – S-acylation is not stable so can only be observed 
indirectly. Hydroxylamine breaks all thioester bonds so no information about the type of acyl 
modification. For low stoichiometry acylation, thiol alkylation must be complete and 
hydroxylamine must not react with other thiol modifications. 
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Outstanding Questions 
-Non-enzymatic protein acylation depends on the concentrations of a large range of acyl-CoA 
species in various tissues and compartments. However, much of the scant available data is 
more than 50 years old. How do the absolute concentration of various acyl-CoA species 
respond to interventions, such as dietary restriction, in different tissues? 
-Many degenerative phenotypes affect post-mitotic tissues such as muscle and brain, yet 
acetylation has generally been studied in regenerative tissues such as liver. Is the low 
acetylation stoichiometry observed in liver also observed in post-mitotic tissues? 
-While the literature contains many lists of acylation sites, acylation stoichiometry at these 
sites is generally not known. How prevalent are other non-enzymatic acyl modifications such 
as succinylation, malonylation, and long-chain fatty acylation? Is their stoichiometry high 
enough to regulate cellular function? 
-Several classes of enzymes and proteins that could limit non-enzymatic acylation have not 
been studied in this context. For example, there are 12 acyl-CoA thioesterases, 3 acyl-CoA 
binding proteins and 11 Zn-dependent deac(et)ylases encoded by the human genome. Are 
they important in limiting non-enzymatic acylation? 
-Most sites of acetylation in mouse are less conserved within other vertebrate genomes. What 
makes acylated protein deleterious and what acyl modifications are the most deleterious? 
 
Outstanding Questions
  
Marked-up manuscript - Editor's comments
Click here to access/download
Marked-up manuscript - Editor's comments
TRACK Changes _TIBS reviewAcylation.docx
S-
S
CoA
O
HO
-S
S
CoA
O
HO
O
O
O
O
S
O
O
O
NH2 HO
O
O
NH HO
O
O
S-
Lys
Glu Glu
GluGlu
Cys Cys
Cys Cys
NH
NHNH
HN
Lys
HN
O
O
O
OO
S
O
R
Acetyl-Histone
Acetyl-CoA CoA Histone
O
S-
NH2
S
O
O
NH2
SH
O
O
H
N
RSH
A B
C
Histone
Histone
James et al. Figure 1
ESA1ESA1
ESA1ESA1 NH
NHNH
NH
NH
S-
Ub
O
HO S
Ub
O
ATP
AMP+PPi
E1
E1
S-
E1
S-
E2
S
Ub
O
E2
E3
S
Ub
O
E2NH
Ub
O
NH2
E3
E2
SH
E3 NH2
S-
S
O
CoA
NH3
+
S
O
CoA
NH2
HN
O
SH
Tau
Tau
Tau
HS
D
HN
O
SHTau
HN
O
SH Tau
HN
O
SHTau
HN
O
SH Tau
Figure 1
HS
N-Acetylated Protein
HS
Protein
NH2
 Protein bound Acetyl-CoA
S
O
S
O
S-Acetylated Protein
S
O
S-Acetylated Transferase
CoA
Transferase bound Acetyl-CoA
S
O
CoA
S
O
CoA
HS
Protein and Transferase
S
O
CoA
HS
N-Acetylated ProteinAcetyl-CoA
Acetyl-CoA
‘ENZYMATIC’
‘NON-ENZYMATIC’
NH2
NH2
NH2
NH2
NH2 NH
O
NH
O
James et al. Key Figure 2
Figure
S
N
H
N
H
O
P
O P O
O
PHO
OH
O
OH
N
N
N
N
NH2
O
O
OHO
OO
O OH
HO
O
N
HO
O
N
H
N
H O
O
OH
O
O
OH
NH2
S
O
S
O
S-Acetyl-CoA
S-Acetyl-Glutathione
S-Acetylated Protein
O-Acetyl-Carnitine
NH2
HS
N-Acetylated Protein
NH
O
METABOLISM
O
O-
O
Acetate
ProteinProtein witha Thiolate
CoA
Thiolate
pKa = ~8.5
Glutathione GlutathioneThiolate
HAGH
AceCS
ACoT
CoA
CoA
CoA + ATP
CrAT
Amine
pKa = ~10.5
Rate Enhanced 
by Proximity
Thiolate
pKa = ~8.5
Amine
pKa = ~10.5
Protein
Thiolate
Glutathione
Thiolate
Protein
Amine
CoA
Protein
AmineAmine
pKa = ~10.5
Glutathione
Protein
Protein
Sirt
Protein
NAD
O-Acetyl-Ribose
James et al. Figure 3
Figure 3
Low stoichiometry
non-enzymatic acylation
General enzymatic  
deacylation of protein
High stoichiometry
 enzymatic acylation of 
protein for regulation 
at some sites
Ancient
Recent
James et al. Figure 4
N-Acylated Protein
NH
O
H
N
O
O
HN
N
H
O
Prone to 
aggregation
Resistant to
Ubiquitination
A B
Figure 4
  
Supplementary Table
Click here to access/download
Author Supplementary Material
SupplementaryTable1.xlsx
  
Submitted paper- Ref 34
Click here to access/download
Author Supplementary Material
Submitted paper_Ref_34.pdf
  
Supplementary calculations
Click here to access/download
Author Supplementary Material
Calculations.docx
Highlights 
-Nucleophilic protein residues can react with the thioester carbonyl of acyl-CoAs leading to 
the continuous transfer acyl groups to protein. Here we discuss the chemistry of this reaction. 
-The cell has a range of mitigating strategies that limit the accumulation of acyl modifications 
on protein. Here we discuss known mechanisms for limiting acyl modifications as well as 
additional proteins that could have a role in preventing acylation. 
-Sites of acylation are less conserved in vertebrates as well as longer-lived mammalian 
species suggesting low-level protein acylation is a stress. Here we discuss how low 
stoichiometry acylation could have deleterious consequences. 
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